Table 1.
Polymorphisms tested in liver samples
| SNP # | SNP ID | Position | MAF |
|---|---|---|---|
| 1 | rs34401238TGT ins | −11231 | 0.023 |
| 2 | rs2737418G>T | −7310 | 0.030 |
| 3 | rs2740574A>G(*1B) | −392 | 0.076 |
| 4 | rs2687105A>T | Intron 2 | 0.080 |
| 5* | rs28988579T>G | Inton 4 | 0.019 |
| 6* | rs35599367C>T | Intron 6 | 0.042 |
| 7* | rs2246709C>T | Intron 7 | 0.269 |
| 8 | rs4646437C>T | Intron 7 | 0.159 |
| 9* | rs2242480G>A | Intron 10 | 0.133 |
| 10* | rs3735451A>G | Intron 12 | 0.133 |
| 11* | rs28988604C>T | 3′UTR | 0.030 |
| 12* | rs28969391delT | 3′UTR | 0.148 |
| 13* | rs28371763A>T | 3′UTR | 0.023 |
Abbreviations: AEI, allelic expression imbalance; MAF, minor allele frequency; SNP, single nucleotide polymorphism.
MAF was derived from all liver samples (cohorts 1 and 2) (reference sequence AF280107).
*
indicates marker SNPs for AEI measurement.